Antitumor activity of didemnin B in the human tumor stem cell assay T. L. JiangR. H. LiuS. E. Salmon Original Articles Pages: 1 - 4
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients H. SharmaN. ThatcherB. W. Fox Original Articles Pages: 5 - 7
Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity Edward J. PavlikDaniel E. KenadyRobert C. Flanigan Original Articles Pages: 8 - 15
A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer Geoffrey FalksonHèndré C. Falkson Original Articles Pages: 16 - 18
Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients Carlo Maurizio CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 19 - 22
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer L. PendyalaW. GrecoP. J. Creaven Original Articles Pages: 23 - 28
Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment G. MilanoA. ThyssC. M. Lalanne Original Articles Pages: 29 - 32
Lack of activity of cyclophosphamide in ovarian cancer patients refractory to cis-dichlorodiammine platinum C. SessaM. D'IncalciC. Mangioni Original Articles Pages: 33 - 34
cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma Andrea VeronesiVittorina ZagonelEligio Grigoletto Original Articles Pages: 35 - 37
Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma Claudia GrecoGabriella ZupiGianna Badaracco Original Articles Pages: 38 - 42
A phase I–II study of combination therapy with thymidine and cytosine arabinoside R. FramP. MajorD. Kufe Original Articles Pages: 43 - 47
Phase II study of chlorozotocin in islet cell carcinoma Ronald M. BukowskiJoseph D. McCrackenCarol J. Fabian Original Articles Pages: 48 - 50
Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma Enrico GarattiniTina ColomboClaudio Pantarotto Original Articles Pages: 51 - 55
Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML) Ama Z. S. RohatinerFrances R. BalkwillT. Andrew Lister Original Articles Pages: 56 - 58
Phase-I study of α-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934) Per DombernowskyBirthe LundHeine Høi Hansen Original Articles Pages: 59 - 61
An investigation of the mouse as a model for vincristine toxicity Steadman D. Harrison Jr Original Articles Pages: 62 - 65
Oral levonantradol in the control of cancer chemotherapy-induced emesis John WelshFraser StuartKenneth Calman Short Communication Pages: 66 - 67
